Market Overview:
The global goserelin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cancer, increasing awareness about available treatment options, and technological advancements in the field of oncology. Based on type, the global goserelin market is segmented into 3.6mg implant and 10.8mg implant segments.
Product Definition:
Goserelin is a gonadotropin-releasing hormone agonist (GnRH agonist) used as a fertility medication to treat infertility in women and men. It is also used to prevent early puberty in girls, and to treat prostate cancer.
3.6mg Implant:
3.6mg implant is a form of goserelin, which is an anti-cancer drug used to treat cancer in the prostate gland, and it's growth factor is called as Gs antigen. It works by shrinking or destroying the cells that are found in the prostate gland that forms tumors.
10.8mg Implant:
Goserelin (Zolgensma) is a subcutaneously delivered, long-acting, synthetic form of a natural hormone - growth hormone. It is used to treat adults who have been diagnosed with Growth Hormone Deficiency (GHID), which occurs when the body does not produce enough growth hormone due to disease or injury.
Application Insights:
The breast cancer segment dominated the global goserelin market in terms of revenue share in 2017. This is due to the rising prevalence of breast cancer and increasing research initiatives by various players involved in the value chain for developing new products for treating this disease. For instance, Pfizer developed a drug called Zoladex that is used as a hormonal therapy for postmenopausal women with hormone-receptor-positive breast carcinoma.
Goserelin implant was approved by U.S FDA (Food and Drug Administration) for use within 5 years from date of approval under Prescribing Information (PI) issued by FDA after completion of Phase 3 clinical trials.
Regional Analysis:
North America dominated the global goserelin market in 2017. This is attributed to the presence of a large number of patients suffering from endometriosis and breast cancer, high adoption rate for new technologies, and supportive reimbursement framework in this region. In addition, increasing R&D expenditure by major companies is expected to fuel growth during the forecast period. For instance, every year Pfizer Inc spends around USD X million on research & development activities pertaining to its portfolio of pharmaceutical products.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising awareness about gynecological disorders among women population resulting into high demand for hormonal therapy products such as goserelin implant which are used for long-term maintenance therapy after initial treatment completion thus boosting revenue share in this region during the forecast period.
Growth Factors:
- Increasing incidence of prostate cancer: The incidence of prostate cancer is increasing globally. This will drive the demand for goserelin as a treatment for the disease.
- Growing awareness about goserelin therapy: There is growing awareness among patients and healthcare professionals about the benefits of goserelin therapy for various indications such as prostate cancer, breast cancer, and endometriosis. This will boost the demand for goserelin in the coming years.
- Launch of new products: Several pharmaceutical companies are launching new products based on goserelin in different regions across the world. This will increase competition in the market and help to drive down prices, thus benefiting consumers/patients greatly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Goserelin Market Research Report
By Type
3.6mg Implant, 10.8mg Implant
By Application
Breast Cancer, Prostate Cancer, Endometriosis
By Companies
AstraZeneca, TerSera Therapeutics, Luye Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Goserelin Market Report Segments:
The global Goserelin market is segmented on the basis of:
Types
3.6mg Implant, 10.8mg Implant
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast Cancer, Prostate Cancer, Endometriosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- TerSera Therapeutics
- Luye Pharma
Highlights of The Goserelin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 3.6mg Implant
- 10.8mg Implant
- By Application:
- Breast Cancer
- Prostate Cancer
- Endometriosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Goserelin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Goserelin is a hormone that stimulates the release of growth hormone from the pituitary gland. Goserelin is used to treat conditions such as anorexia and obesity.
Some of the major players in the goserelin market are AstraZeneca, TerSera Therapeutics, Luye Pharma.
The goserelin market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Goserelin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Goserelin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Goserelin Market - Supply Chain
4.5. Global Goserelin Market Forecast
4.5.1. Goserelin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Goserelin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Goserelin Market Absolute $ Opportunity
5. Global Goserelin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Goserelin Market Size and Volume Forecast by Type
5.3.1. 3.6mg Implant
5.3.2. 10.8mg Implant
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Goserelin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Goserelin Market Size and Volume Forecast by Application
6.3.1. Breast Cancer
6.3.2. Prostate Cancer
6.3.3. Endometriosis
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Goserelin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Goserelin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Goserelin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Goserelin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Goserelin Demand Share Forecast, 2019-2026
9. North America Goserelin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Goserelin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Goserelin Market Size and Volume Forecast by Application
9.4.1. Breast Cancer
9.4.2. Prostate Cancer
9.4.3. Endometriosis
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Goserelin Market Size and Volume Forecast by Type
9.7.1. 3.6mg Implant
9.7.2. 10.8mg Implant
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Goserelin Demand Share Forecast, 2019-2026
10. Latin America Goserelin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Goserelin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Goserelin Market Size and Volume Forecast by Application
10.4.1. Breast Cancer
10.4.2. Prostate Cancer
10.4.3. Endometriosis
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Goserelin Market Size and Volume Forecast by Type
10.7.1. 3.6mg Implant
10.7.2. 10.8mg Implant
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Goserelin Demand Share Forecast, 2019-2026
11. Europe Goserelin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Goserelin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Goserelin Market Size and Volume Forecast by Application
11.4.1. Breast Cancer
11.4.2. Prostate Cancer
11.4.3. Endometriosis
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Goserelin Market Size and Volume Forecast by Type
11.7.1. 3.6mg Implant
11.7.2. 10.8mg Implant
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Goserelin Demand Share, 2019-2026
12. Asia Pacific Goserelin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Goserelin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Goserelin Market Size and Volume Forecast by Application
12.4.1. Breast Cancer
12.4.2. Prostate Cancer
12.4.3. Endometriosis
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Goserelin Market Size and Volume Forecast by Type
12.7.1. 3.6mg Implant
12.7.2. 10.8mg Implant
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Goserelin Demand Share, 2019-2026
13. Middle East & Africa Goserelin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Goserelin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Goserelin Market Size and Volume Forecast by Application
13.4.1. Breast Cancer
13.4.2. Prostate Cancer
13.4.3. Endometriosis
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Goserelin Market Size and Volume Forecast by Type
13.7.1. 3.6mg Implant
13.7.2. 10.8mg Implant
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Goserelin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Goserelin Market: Market Share Analysis
14.2. Goserelin Distributors and Customers
14.3. Goserelin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AstraZeneca
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. TerSera Therapeutics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Luye Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
